You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

13 February 2019

Cryptococcal meningitis screening is worth the money in Uganda

Cost should not be a barrier for the full implementation of cryptococcal meningitis screening programmes for people living with HIV as per World Health Organization recommendations.

0
28 January 2019

Viral suppression more likely among youth using single-tablet antiretroviral treatment regimes

New research reveals that, like adults, young people have better treatment outcomes with a lower pill burden.

0
07 January 2019

‘RAPID’ HIV treatment initiation a success in San Francisco

Populations considered hard to treat or engage in care can benefit from same-day antiretroviral treatment as part of a clinic offering social safety-net interventions.

0
03 January 2019

Location inherently linked to unsuppressed viral load among young South African women

Multiple partners, migration, and living in an HIV ‘hotspot’ have been identified as key drivers of unsuppressed viral load among young women living with HIV in KwaZulu-Natal, South Africa.

0
14 December 2018

Adolescents living with HIV are struggling to stay in treatment 

New research reveals high rates of loss to follow-up among adolescents, with rates among those acquiring the infection in their teens nearly three times that of those infected perinatally. 

0
06 June 2018

'Emotional closeness’ key to successful HIV treatment support

The type of relationship someone living with HIV has with both their social network and a nominated ‘treatment partner’ is likely to influence whether they are virally suppressed, research from Botswana suggests.

0
24 May 2018

Children born with HIV on treatment experience next-to-no developmental set-backs at the age of 5

New data on the impact of different treatment strategies on the neuro-development of young children living with HIV has been released, showing normal development in all areas apart from visual perception.

0
12 April 2018

India could shift from efavirenz to dolutegravir for HIV treatment – at no extra cost, new research suggests

Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.

0
16 February 2018

People in poorer countries in Latin America and the Caribbean adhere better to HIV treatment

New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions. 

0
05 February 2018

New data helps prioritise groups for HIV treatment in low resourced settings

Lancet study reveals for the first time who can benefit most from immediate antiretroviral treatment – enabling prioritisation in low-resourced settings. But who is left behind?

0